AptarGroup with ticker code (ATR) now have 6 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 132 and 110 calculating the mean target price we have 122.33. Given that the stocks previous close was at 114.56 this would indicate that there is a potential upside of 6.8%. The day 50 moving average is 111.9 and the 200 day moving average is 105.3. The company has a market capitalisation of $7,506m. Visit the company website at: https://www.aptar.com
The potential market cap would be $8,015m based on the market concensus.
AptarGroup designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company primarily sells its products and services through its own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
